Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204)
一项针对接受术前放化疗的 II 期或 III 期直肠癌患者的术后奥沙利铂、5-氟尿嘧啶和亚叶酸钙与奥沙利铂、5-氟尿嘧啶、亚叶酸钙和贝伐珠单抗的组间随机 III 期研究：ECOG-ACRIN 研究组的一项试验 (E5204)
期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0437
Chakravarthy, A Bapsi; Zhao, Fengmin; Meropol, Neal J; Flynn, Patrick J; Wagner, Lynne I; Sloan, Jeffrey; Diasio, Robert B; Mitchell, Edith P; Catalano, Paul; Giantonio, Bruce J; Catalano, Robert B; Haller, Daniel G; Awan, Rashid A; Mulcahy, Mary F; O'Brien, Timothy E; Santala, Roger; Cripps, Christine; Weis, John R; Atkins, James N; Leichman, Cynthia G; Petrelli, Nicholas J; Sinicrope, Frank A; Brierley, James D; Tepper, Joel E; O'Dwyer, Peter J; Sigurdson, Elin R; Hamilton, Stanley R; Cella, David; Benson, Al B 3rd
